📰 Cingulate Inc News
Page 8 - Cingulate Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cingulate Inc. Real-time updates on events, politics, business and more.
May 13, 2023
Cingulate (NASDAQ:CING – Get Rating) posted its quarterly earnings results on Wednesday. The company reported ($0.35) earnings per share for the quarter, missing the consensus estimate of ($0.27) by ($0.08), reports. Cingulate Price Performance Shares of NASDAQ:CING opened at $1.02 on Friday. The company has a quick ratio of 1.12, a current ratio of 1.12 […]
May 12, 2023
KANSAS CITY, Kan., May 12, 2023 -- Cingulate Inc. , a biopharmaceutical company utilizing its proprietary Precision Timed Release™ drug delivery platform technology to build and advance a... | June 14, 2023
May 10, 2023
Additional $3 Million of Financing Proprietary PTR™ Manufacturing Processes Successfully Transferred to Societal CDMO Joint Commercialization Agreement for...
May 5, 2023
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT ... | May 5, 2023
May 3, 2023
Scalable Supply of CTx-1301 Ready to be Produced with Cingulate on Track to Meet Previously Announced Clinical Timelines for Phase 3 Trial ProgramKANSAS CITY, Kan., May 03, 2023 -- Cingulate Inc. ,... | May 3, 2023
May 3, 2023
Cingulate Announces Successful Transfer of CTx-1301 Proprietary PTR™ Manufacturing Processes to Societal CDMO Scalable Supply of CTx-1301 Ready to be... | May 3, 2023
April 20, 2023
Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities...
April 14, 2023
KANSAS CITY, Kan., April 14, 2023 -- Cingulate Inc. , a biopharmaceutical company utilizing its proprietary Precision Timed Release™ drug delivery platform technology to build and advance a... | April 14, 2023
April 14, 2023
KANSAS CITY, Kan., April 14, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision...
March 30, 2023
Cingulate Inc. (NASDAQ:CING – Get Rating) was the recipient of a large drop in short interest in March. As of March 15th, there was short interest totalling 404,000 shares, a drop of 62.2% from the February 28th total of 1,070,000 shares. Based on an average daily volume of 848,400 shares, the days-to-cover ratio is currently […]